BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Dextrorphan

a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN.

300+ PubMed studies analyzed · 18 RCTs · Evidence Score: 44.4

Research Domains

Dextrorphan has been studied across 18 research domains including 💊 Pain, 🫁 Liver & Detox, 🧠 Neuroprotection, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is 💊 Pain with 13% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dextrorphan, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

D-Aspartic
7 shared targets
Dizocilpine
7 shared targets
Aspartic
7 shared targets
cycloserine
7 shared targets
Ibotenic
7 shared targets
Levorphanol
9 shared targets
Glycine
7 shared targets
ifenprodil
5 shared targets
Dextromethorphan
9 shared targets
Dextrothyroxine
7 shared targets
Loading evidence profile...

This evidence profile for Dextrorphan is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.